Home/Filings/4/0001209191-24-003743
4//SEC Filing

Cuffe Michael S. 4

Accession 0001209191-24-003743

CIK 0000860730other

Filed

Feb 20, 7:00 PM ET

Accepted

Feb 21, 7:29 PM ET

Size

13.1 KB

Accession

0001209191-24-003743

Insider Transaction Report

Form 4
Period: 2024-02-16
Cuffe Michael S.
EVP and Chief Clinical Officer
Transactions
  • Award

    Common Stock

    2024-02-16+12,56037,488.967 total
  • Tax Payment

    Common Stock

    2024-02-16$308.55/sh6,212$1,916,71335,696.967 total
  • Award

    Common Stock

    2024-02-16+4,42041,908.967 total
Footnotes (2)
  • [F1]On February 3, 2021, the reporting person was granted 6,280 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2021-2023. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2021-2023 earnings per share, the number of performance share units that vested equaled 200% of the units granted.
  • [F2]On October 25, 2021, the reporting person was granted 2,210 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2021-2023. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2021-2023 earnings per share, the number of performance share units that vested equaled 200% of the units granted.

Issuer

HCA Healthcare, Inc.

CIK 0000860730

Entity typeother

Related Parties

1
  • filerCIK 0001632835

Filing Metadata

Form type
4
Filed
Feb 20, 7:00 PM ET
Accepted
Feb 21, 7:29 PM ET
Size
13.1 KB